TrialDiabetes2014

Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans.

Changting Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.